• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Patanjali's COVID-19 cure Coronil launched; All you need to know

|

New Delhi, June 23: Yoga guru Ramdev-run Patanjali Ayurved on Tuesday launched Coronil and Swasari, an Ayurvedic medicine, to help treat the novel coronavirus or Covid-19 infection on Tuesday at Patanjali Yogpeeth in Haridwar, Uttarakhand.

Coronil: Patanjalis COVID-19 drug

During the launch, Baba Ramdev said that the medicine has shown '100 per cent recovery rate within 3-7 days'.

Baba Ramdev had revealed that COVID-19 patients who were given Coronil - which is made from a mixture of Ashwagandha, Giloy and Tulsi - showed 100 per cent recovery rate.

'All parametres met’: Patanjali after notice over COVID breakthrough claim

Coronil is the first evidence-based ayurvedic medicine for coronavirus contagion. The medicine has been developed in joint research by Patanjali Research Insitute, National Institue of Medical Science, Jaipur. Almost 500 scientists of the Patanjali worked tirelessly to find a cure for coronavirus.

Patanjalis COVID-19 cure Coronil launched; All you need to know
    Army sources revealed there was a mutual consensus to disengage at India China top military talks

    Patanjali's Chief Executive Officer (CEO), Acharya Balkrishna, had earlier claimed that the company has found a cure for was able to cure at least 1,000 coronavirus patients within 5-14 days.

    According to the company they have conducted 'randomized placebo-controlled clinical trials' and during the conference, they will reveal the outcome of the test.

    "We appointed a team of scientists after the Covid-19 outbreak. First, the simulation was done and compounds were identified which can fight the virus and stop its spread in the body. Then, we conducted a clinical case study on hundreds of positive patients and we have got 100 per cent favourable results. We are not talking about an immunity booster. We are talking about a cure," Patanjali CEO Acharya Balkrishna said in Haridwar, according to ANI.

    Stop advertising 'Coronil' as COVID cure; prove claims scientifically first: Govt tells Patanjali

    Apart from Patanjali, three other drugs were launched by Indian pharma companies for emergency care of Covid-19 patients. On Saturday Glenmark Pharmaceuticals launched the antiviral drug Favipiravir under the name Fabiflu, and it was followed by the launch of the anti-viral drug Remdesivir by pharma companies Cipla and Hetero under the brand name Cipremi and Covifor respectively.

    When will it be available?

    This will be available in 8 to 10 days

    For Daily Alerts
    Get Instant News Updates
    Enable
    x
    Notification Settings X
    Time Settings
    Done
    Clear Notification X
    Do you want to clear all the notifications from your inbox?
    Settings X